Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China

Overview

Journal Front Oncol

Specialty Oncology

Date 2020 Sep 25

PMID 32974193

Citations 6

Authors

Shichuan Zhang

Shuang Yang

Peng Xu

Yun Xu

Guanqun Zhou

Xiaomin Ou

Runye Wu

Mei Lan

Davide Fontanarosa

Jason Dowling

Xiaoshen Wang

Shaojun Lin

Jun-Lin Yi

Ying Sun

Chaosu Hu

Jinyi Lang

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study is to investigate the current status of clinical target volume (CTV) delineation for primary site of nasopharyngeal cancer (NPC) among five large tertiary cancer centers in China.

Materials And Methods: The simulation CT and MR images of a patient with T3N2M0 NPC were sent to the centers participating. Fourteen experienced physicians contoured the targets independently, and the outlined structures were compared. The consistency and differences among these 14 CTVs are discussed.

Results: Two different CTV designs were used in the centers. "One-CTV" design defines one CTV with a dose of 60 Gy, whereas "two-CTV" design has a high-risk CTV with dose of 60 Gy and a medium risk CTV with dose of 54 Gy. We found that the coverage of prophylactic area is very consistent between these two designs. The variances on the coverage of some sites were also significant among physicians, including covering cavernous sinus at un-involved side, posterior space of styloid process, and caudal border on posterior pharyngeal wall.

Conclusions: Standardization is the main requirement for personalization of care; our study shows that among the 14 physicians in the five centers the coverage of prophylactic areas is in excellent agreement. Two distinct strategies on CTV design are currently being used, and multiple controversies were found, suggesting further optimization of CTV for primary site of NPC is needed.

Citing Articles

Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders.

Yip P, You R, Chen M, Chua M Cancers (Basel). 2024; 16(2).

PMID: 38254872 PMC: 10814653. DOI: 10.3390/cancers16020383.

Application value of 3D pCASL in early assessment of potential radiation encephalopathy in nasopharyngeal carcinoma patients undergoing radiotherapy.

He Y, Guo J, Ding Y, Zhou L, Jiang X, Zhen C Br J Radiol. 2023; 96(1149):20200448.

PMID: 37393533 PMC: 10461280. DOI: 10.1259/bjr.20200448.

Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation.

Ou X, Yan W, Huang Y, He X, Ying H, Lu X Radiat Oncol. 2023; 18(1):55.

PMID: 36944958 PMC: 10032020. DOI: 10.1186/s13014-023-02199-3.

Current Radiotherapy Considerations for Nasopharyngeal Carcinoma.

Ng W, Chow J, Beitler J, Corry J, Mendenhall W, Lee A Cancers (Basel). 2022; 14(23).

PMID: 36497254 PMC: 9736118. DOI: 10.3390/cancers14235773.

CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis.

Li Z, Cai X, Zou W, Zhang J Am J Transl Res. 2022; 13(12):13406-13422.

PMID: 35035684 PMC: 8748104.

References

Li W, Sun Y, Chen M, Tang L, Liu L, Mao Y . Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation. Chin J Cancer. 2012; 31(12):579-87. PMC: 3777458. DOI: 10.5732/cjc.012.10095. View

Liu F, Luo T, Jin T, Zhang J, Xiang Z, Yan R . Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study. BMC Cancer. 2019; 19(1):554. PMC: 6556221. DOI: 10.1186/s12885-019-5774-2. View

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J, Pujol S . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012; 30(9):1323-41. PMC: 3466397. DOI: 10.1016/j.mri.2012.05.001. View

Sanford N, Lau J, Lam M, Juliano A, Adams J, Goldberg S . Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience. Int J Radiat Oncol Biol Phys. 2019; 103(3):654-668. DOI: 10.1016/j.ijrobp.2018.10.006. View

Zang J, Li C, Zhao L, Wang J, Xu M, Luo S . Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China. Medicine (Baltimore). 2016; 95(21):e3794. PMC: 4902379. DOI: 10.1097/MD.0000000000003794. View

Billan S, Bakouche V, Borzov E, Gil Z, Abdah-Bortnyak R . Long-term outcomes in patients with nasopharyngeal carcinoma treated with reduced-volume conformal radiotherapy: A retrospective cohort study. J Med Imaging Radiat Oncol. 2018; . DOI: 10.1111/1754-9485.12722. View

Lufkin R, HANAFEE W . Magnetic resonance imaging of the nasopharynx and skull base. Acta Radiol Suppl. 1986; 369:325-6. View

Lang J, Hu C, Lu T, Pan J, Lin T . Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives. Cancer Manag Res. 2019; 11:6365-6376. PMC: 6628961. DOI: 10.2147/CMAR.S197544. View

Sultanem K, Shu H, Xia P, Akazawa C, Quivey J, Verhey L . Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2000; 48(3):711-22. DOI: 10.1016/s0360-3016(00)00702-1. View

10.

Lin L, Dou Q, Jin Y, Zhou G, Tang Y, Chen W . Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma. Radiology. 2019; 291(3):677-686. DOI: 10.1148/radiol.2019182012. View

11.

Dowling J, Sun J, Pichler P, Rivest-Henault D, Ghose S, Richardson H . Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences. Int J Radiat Oncol Biol Phys. 2015; 93(5):1144-53. DOI: 10.1016/j.ijrobp.2015.08.045. View

12.

Lee N, Zhang Q, Pfister D, Kim J, Garden A, Mechalakos J . Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol. 2011; 13(2):172-80. PMC: 4985181. DOI: 10.1016/S1470-2045(11)70303-5. View

13.

Lin S, Pan J, Han L, Zhang X, Liao X, Lu J . Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009; 75(4):1071-8. DOI: 10.1016/j.ijrobp.2008.12.015. View

14.

Kam M, Chau R, Suen J, Choi P, Teo P . Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003; 56(1):145-57. DOI: 10.1016/s0360-3016(03)00075-0. View

15.

Lee A, Ng W, Pan J, Poh S, Ahn Y, AlHussain H . International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2017; 126(1):25-36. DOI: 10.1016/j.radonc.2017.10.032. View

16.

Liang S, Sun Y, Liu L, Chen Y, Chen L, Mao Y . Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation. Int J Radiat Oncol Biol Phys. 2009; 75(3):742-50. DOI: 10.1016/j.ijrobp.2008.11.053. View

17.

Wang X, Yan C, Hu C, Ying H, He X, Zhou Z . Study of the medial group retropharyngeal node metastasis from nasopharyngeal carcinoma based on 3100 newly diagnosed cases. Oral Oncol. 2014; 50(11):1109-13. DOI: 10.1016/j.oraloncology.2014.08.007. View

18.

Wookey V, Appiah A, Kallam A, Ernani V, Smith L, Ganti A . HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck. Anticancer Res. 2019; 39(4):1907-1914. DOI: 10.21873/anticanres.13299. View

19.

Pinter C, Lasso A, Wang A, Jaffray D, Fichtinger G . SlicerRT: radiation therapy research toolkit for 3D Slicer. Med Phys. 2012; 39(10):6332-8. DOI: 10.1118/1.4754659. View

20.

Tham I, Hee S, Yeo R, Salleh P, Lee J, Tan T . Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Int J Radiat Oncol Biol Phys. 2009; 75(5):1481-6. DOI: 10.1016/j.ijrobp.2009.01.018. View